Back to search

France· FR:65077051

INVANZ 1 g, poudre pour solution à diluer pour perfusion

A ertapenem product containing ertapénem sodique, registered in France by MERCK SHARP & DOHME (PAYS-BAS). The same ATC class is registered in 16 of our 19 countries.

ATC J01DH03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedINVANZ 1 g, poudre pour solution à di…ATCJ01DH03REGISTER NO.FR:65077051PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Ertapenem is registered in 16 of 19 countries.

Countries holding a registration under ATC J01DH03 (ertapenem), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose

Ertapenem · ATC J01DH03

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ertapenem costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ertapenem · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$74.64
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ERTAPÉNEM SODIQUE
Manufacturer
MERCK SHARP & DOHME (PAYS-BAS)
Country
France (FR)
ATC code
J01DH03
ATC class
Ertapenem
Defined daily dose
1 g, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400956491650
    1 flacon(s) en verre

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

56 interactions on record for ertapenem.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ertapenem · interactions on record

56 records

  • 4 severe
  • 13 moderate
  • 38 info

Most severe, free to view

  • BupropionN06AX12severe
  • BupropionN07BA02severe
  • IohexolV08AB02severe
  • IopamidolV08AB04severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ertapenem in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ertapenem products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
  • Bulgaria · Ертапенем Аптафарма
  • Cyprus · Ertapenem Aptapharma
  • Czechia · Ertapenem Aptapharma, Ertapenem Ash
  • Germany · Ertapenem Steriscience
  • Denmark · Ertapenem "aptapharma", Ertapenem Fresenius Kabi
  • Estonia · Ertapenem Fresenius Kabi, Ertapenem Qilu
  • Spain · Ertapenem, Ertapenem Aurovitas
  • Finland · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
  • United Kingdom (Northern Ireland) · Ertapenem Acs Dobfar, Ertapenem Aspire Pharma
  • Greece · Ertapenem Anfarm
  • Croatia · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
  • Hungary · Ertapenem Anfarm, Ertapenem Aptapharma
  • Iceland · Invanz
  • Italy · Ertapenem Acs Dobfar, Ertapenem Aurobindo
  • Liechtenstein · Invanz
  • Lithuania · Ertapenem Qilu
  • Latvia · Ertapenem Qilu
  • Malta · Ertapenem Aptapharma
  • Netherlands · Ertapenem Added Pharma, Ertapenem Aptapharma
  • Norway · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
  • Poland · Ertapenem Aptapharma, Ertapenem Eugia
  • Portugal · Ertapenem, Ertapenem Aurovitas
  • Romania · Ertapenem Acs Dobfar, Ertapenem Aptapharma
  • Sweden · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
  • Slovenia · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
  • Slovakia · Ertapenem Aptapharma, Ertapenem Ash

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fcabce57-3986-442c-b343-db552a6340e1
GET /v1/drugs/fcabce57-3986-442c-b343-db552a6340e1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65077051",
  "date_amm": "2002-04-18",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/02/216",
  "substance": "ERTAPÉNEM SODIQUE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about ertapenem.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.